Target intelligence / Profile preview

Norovirus GII.4 VP1 capsid protein (VP1)

Target
VP1
Molecular classification
Viral capsid protein
01

Overview

The Norovirus GII.4 VP1 capsid protein is the major structural component of the GII.4 norovirus virion, a leading cause of viral gastroenteritis worldwide, forming 180 copies arranged in T=3 icosahedral symmetry with shell (S), protruding P1, and P2 domains. The S domain encases the positive-sense single-stranded RNA genome, while P domains create surface protrusions critical for flexibility, receptor binding to histo-blood group antigens (HBGAs) via P2 subdomain pockets, and host cell entry. GII.4 VP1 exhibits dynamic conformations, including "resting" and "rising" states influenced by divalent ions, enabling environmental stability and replication. Rapid evolution in the VP1 gene, especially under positive selection in shell and P domains, drives antigenic variants (e.g., Den Haag, Sydney) that evade immunity, sustaining epidemics over decades. This variability hinders vaccine efforts, as neutralizing antibodies target conserved yet mutable P2 sites, with no approved antiviral drugs directly interacting.

Other names
Major capsid proteinViral protein 1
02

Biological functions

Encapsidation of viral genomeReceptor binding (histo-blood group antigens)Host cell entryImmune evasion through antigenic variation
03

Disease associations

Infection (gastroenteritis)
04

Safety considerations

Antigenic drift complicating vaccine developmentHigh evolutionary rate leading to variant emergence

Beyond the preview

Go deeper on Norovirus GII.4 VP1 capsid protein (VP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norovirus GII.4 VP1 capsid protein (VP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call